Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haplo-Cord vs Double Cord Transplant in Hematologic Malignancies
NCT01745913Phase 2Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Oct 2012
- Primary completion
- Apr 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of haploidentical hematopoietic stem cells in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), acute lymphoblastic leukemia (ALL), Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), sponsored by Weill Cornell Medicine. Started Oct 2012; status: terminated.
02
Drugs
haploidentical hematopoietic stem cells
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)acute lymphoblastic leukemia (ALL)Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01745913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01745913.